España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Optimi Health
OPTHF
OTCQX
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.1639
0.00628
3.98%
At close: -
$0.1510
-0.01
-7.87%
After Hours: Oct 31, 9:26 AM EDT
Get Report
Comment
Optimi Health (OPTHF) Forecast
News
Earnings
Optimi Health (OPTHF) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Optimi Health (OTC:OPTHF) Stock
Optimi Health Stock (OTC: OPTHF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, September 16, 2024
Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition
Juan Spínelli
Thursday, June 06, 2024
New Milestone In Psychedelics Market: Canadian Start-Up Will Export Psilocybin And MDMA To Australia
Rolando García
Wednesday, April 17, 2024
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Lara Goldstein
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
Lara Goldstein
Tuesday, April 09, 2024
Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute
Lara Goldstein
Tuesday, March 26, 2024
Two Top Biotechs Forge MDMA Supply Deals For An Expanding Research Field
Lara Goldstein
Saturday, March 16, 2024
Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
Lara Goldstein
Saturday, March 02, 2024
Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More
Lara Goldstein
Friday, January 26, 2024
Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
Lara Goldstein
Monday, January 08, 2024
Psychedelics Headlines: Magic Mushrooms For Sexual Wellbeing, The DEA's Stance, The Therapist's Role & More
Lara Goldstein
Monday, September 11, 2023
Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
Lara Goldstein
Friday, September 08, 2023
Optimi Health Will Supply Psychedelics To Canada's SAP, Secures CA$1M Private Financing
Lara Goldstein
Monday, August 14, 2023
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
Lara Goldstein
Tuesday, August 01, 2023
Natural Psilocybin Companies Diversify: Latest By Optimi, Red Light Holland And A European Player
Lara Goldstein
Tuesday, June 20, 2023
Psyched: $75M In Federal Funds, Gov. Polis Opens MAPS Event, CNN's Show, Dock Ellis' LSD Pitch & More
Lara Goldstein
MDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian University
Lara Goldstein
Tuesday, May 23, 2023
Psyched: New Psilocybin Forms, LSD Anxiety Study, UK's Parliamentary Debate And More
Lara Goldstein
Wednesday, May 17, 2023
The Psychedelic Mushrooms Market; Between Legitimate Harvesting And Illegal Retail Sales
Lara Goldstein
Monday, May 15, 2023
Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More
Lara Goldstein
Thursday, May 11, 2023
Optimi Health Boosts Psilocybin Production With New Health Canada License And Supply Deal
Lara Goldstein
Monday, April 03, 2023
What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry
Javier Hasse
Tuesday, March 07, 2023
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
Lara Goldstein
Monday, March 06, 2023
Australia Receives First Batch Of Clinical-Grade Psilocybin From Mindset Pharma And PharmAla
Lara Goldstein
Thursday, March 02, 2023
Latest Psychedelics Deals: Optimi Supplies Australia, Awakn Partners Licensing In California
Lara Goldstein
Monday, February 13, 2023
Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More
Lara Goldstein
Thursday, February 09, 2023
How Do Psilocybin And MDMA Work Together? This Proposed Experiential Study Is Set To Find Out
Lara Goldstein
Monday, February 06, 2023
MDMA News: Optimi's New Drug Now Available, Revive Advances Transdermal Patch Evaluations
Lara Goldstein
Wednesday, January 25, 2023
Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More
Lara Goldstein
Saturday, January 21, 2023
Here Are The Latest Psychedelics Partnerships From Production & Supply Chain To Community Action
Lara Goldstein
Thursday, October 20, 2022
Canada Update: Psychedelics Legal Landscape, Overview & Near-Term Predictions
Lara Goldstein
Tuesday, October 11, 2022
Optimi Closes Non-Brokered Private Placement, Here Are The Details
Lara Goldstein
Thursday, September 22, 2022
Two Psychedelics Companies Will Study Effects Of Natural Psilocybin And MDMA In Healthy Volunteers
Lara Goldstein
Wednesday, September 07, 2022
Psychedelic Mushrooms Are Going Global: Supply Deal With UK-Based Wellness Company Moves Forward
Lara Goldstein
Friday, September 02, 2022
New Biosynthetic Psilocybin Hits The Psychedelics Market, Available For Research And Clinical Trials
Lara Goldstein
Thursday, September 01, 2022
Magic Mushrooms Producer Optimi Keeps Betting On The FDA-approval Of Psychedelics
Lara Goldstein
Tuesday, August 30, 2022
First International Psilocybin Supply Agreement For Optimi Health: Here Are The Details
Joana Scopel
Tuesday, August 16, 2022
Optimi Health Given Green Light To Produce And Distribute MDMA In Canada, The Legal Landscape Ahead
Lara Goldstein
Wednesday, August 10, 2022
Meet Blue Serenity, Canada's First Natural Therapeutic Psilocybin Product For Approved Patients
Lara Goldstein
Monday, August 08, 2022
What A Collab! Optimi Health & Patient Advocate Thomas Hartle's New Medical Psilocybin Venture
Lara Goldstein
Wednesday, July 13, 2022
New Optimi Supply Agreement: Psilocybin For Phase 1 Trial On Microdosing For Wellbeing, No Hallucinogenic Effects
Lara Goldstein
Tuesday, June 28, 2022
HAVN Life Sciences & Optimi Health Corp Announce Supply Agreements, Here Are The Details
Lara Goldstein
Wednesday, June 15, 2022
Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill
Natan Ponieman
Wednesday, June 08, 2022
Shrooms Move Forward For Palliative Care, Optimi To Supply High-Grade Psilocybin For Private Mental Health Practitioner In CA
Lara Goldstein
Tuesday, May 31, 2022
Optimi Health Signs Two New Supply Agreements In Less Than a Week
Lara Goldstein
Wednesday, May 25, 2022
Optimi Completes First Grow of Psilocybin Mushrooms, Introduces New Head Of Cultivation
Lara Goldstein
Psyched: Medical Psychedelics In Davos, Canadian Sen Does Psychedelics, Ei.Ventures & Mycotopia To Merge Into $383M Company
Natan Ponieman
Wednesday, May 18, 2022
Optimi Health Adds Large Portfolio Of Magic Mushrooms Strains To Its Genetic Bank
Fermin Orgambide
Monday, October 18, 2021
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
Natan Ponieman
Wednesday, October 13, 2021
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Natan Ponieman
Show More
